Progesterone Receptors Drive Advanced Breast Cancer Phenotypes Including Circulating tumor- and Stem-Like Cell Expansion in the Context of ESR1 Mutation

Scientists investigated progesterone receptor-dependent transcriptional programs such as the unfolded protein response that can be leveraged to target CSCs in Y537S estrogen receptor gene (ESR1)-mutant breast cancer.